Array BioPharma: Pfizer Completes Acquisition of Array Biopharma
Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need.
Read full article »
CEO
Array is a biopharmaceutical company that researches, develops and commercializes targeted small molecule medicines to treat cancer.
Read more